Pictet Asset Management (UK)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $168M | Buy |
1,722,709
+160,186
| +10% | +$15.6M | 0.18% | 164 |
|
|
2021
Q1 | $152M | Sell |
1,562,523
-134,467
| -8% | -$13.1M | 0.18% | 156 |
|
|
2020
Q4 | $163M | Buy |
1,696,990
+366,467
| +28% | +$35.1M | 0.21% | 136 |
|
|
2020
Q3 | $128M | Buy |
1,330,523
+23,769
| +2% | +$2.29M | 0.2% | 150 |
|
|
2020
Q2 | $159M | Buy |
1,306,754
+402,559
| +45% | +$49.1M | 0.27% | 111 |
|
|
2020
Q1 | $78.3M | Buy |
904,195
+48,441
| +6% | +$4.19M | 0.17% | 163 |
|
|
2019
Q4 | $92M | Sell |
855,754
-185,246
| -18% | -$19.9M | 0.16% | 167 |
|
|
2019
Q3 | $93.8M | Buy |
1,041,000
+91,310
| +10% | +$8.23M | 0.2% | 142 |
|
|
2019
Q2 | $80.2M | Sell |
949,690
-29,518
| -3% | -$2.49M | 0.17% | 156 |
|
|
2019
Q1 | $86.3M | Buy |
979,208
+39,729
| +4% | +$3.5M | 0.19% | 154 |
|
|
2018
Q4 | $67.1K | Buy |
939,479
+61,486
| +7% | +$4.39K | 0.17% | 171 |
|
|
2018
Q3 | $108M | Sell |
877,993
-38,536
| -4% | -$4.74M | 0.23% | 135 |
|
|
2018
Q2 | $90M | Sell |
916,529
-23,342
| -2% | -$2.29M | 0.22% | 144 |
|
|
2018
Q1 | $77.9M | Sell |
939,871
-180,790
| -16% | -$15M | 0.19% | 160 |
|
|
2017
Q4 | $87M | Sell |
1,120,661
-225,194
| -17% | -$17.5M | 0.22% | 142 |
|
|
2017
Q3 | $82.5M | Buy |
1,345,855
+204,996
| +18% | +$12.6M | 0.23% | 133 |
|
|
2017
Q2 | $49.6M | Buy |
1,140,859
+124,965
| +12% | +$5.43M | 0.15% | 183 |
|
|
2017
Q1 | $44M | Buy |
1,015,894
+234,157
| +30% | +$10.1M | 0.14% | 195 |
|
|
2016
Q4 | $30.3M | Buy |
781,737
+85,359
| +12% | +$3.3M | 0.11% | 238 |
|
|
2016
Q3 | $35.3M | Sell |
696,378
-8,851
| -1% | -$448K | 0.13% | 212 |
|
|
2016
Q2 | $35M | Buy |
705,229
+513,172
| +267% | +$25.5M | 0.14% | 202 |
|
|
2016
Q1 | $7.06M | Buy |
192,057
+40,303
| +27% | +$1.48M | 0.03% | 460 |
|
|
2015
Q4 | $8.59M | Buy |
151,754
+124,254
| +452% | +$7.03M | 0.04% | 436 |
|
|
2015
Q3 | $1.09M | Buy |
+27,500
| New | +$1.09M | ﹤0.01% | 775 |
|